230 related articles for article (PubMed ID: 12601175)
21. A CRM1-dependent nuclear export pathway is involved in the regulation of MutLα subcellular localization.
Brieger A; Adam R; Passmann S; Plotz G; Zeuzem S; Trojan J
Genes Chromosomes Cancer; 2011 Feb; 50(2):59-70. PubMed ID: 21064154
[TBL] [Abstract][Full Text] [Related]
22. c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association.
Ben-Yehoyada M; Ben-Dor I; Shaul Y
J Biol Chem; 2003 Sep; 278(36):34475-82. PubMed ID: 12824179
[TBL] [Abstract][Full Text] [Related]
23. Nuclear import of human MLH1, PMS2, and MutLalpha: redundancy is the key.
Leong V; Lorenowicz J; Kozij N; Guarné A
Mol Carcinog; 2009 Aug; 48(8):742-50. PubMed ID: 19148896
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of the DNA mismatch repair factor, PMS2, confers hypermutability and DNA damage tolerance.
Gibson SL; Narayanan L; Hegan DC; Buermeyer AB; Liskay RM; Glazer PM
Cancer Lett; 2006 Dec; 244(2):195-202. PubMed ID: 16426742
[TBL] [Abstract][Full Text] [Related]
25. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
26. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
27. Expression of mismatch repair gene PMS2 in nasopharyngeal carcinoma and regulation by glycogen synthase kinase-3β in vivo and in vitro.
Fang J; Lei W; Huang X; Li P; Chen X; Zhu X; Wen W; Li H
Auris Nasus Larynx; 2012 Feb; 39(1):71-6. PubMed ID: 21571466
[TBL] [Abstract][Full Text] [Related]
28. Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinoma.
Zhang Y; Shu YM; Wang SF; Da BH; Wang ZH; Li HB
BMC Cancer; 2010 Feb; 10():58. PubMed ID: 20178594
[TBL] [Abstract][Full Text] [Related]
29. Identification of the interleukin 4 receptor alpha gene as a direct target for p73.
Sasaki Y; Mita H; Toyota M; Ishida S; Morimoto I; Yamashita T; Tanaka T; Imai K; Nakamura Y; Tokino T
Cancer Res; 2003 Dec; 63(23):8145-52. PubMed ID: 14678968
[TBL] [Abstract][Full Text] [Related]
30. Effects of p73 gene overexpression on apoptosis and chemosensitivity of human lung adenocarcinoma cell line A549.
He Y; Fan SZ; Jiang YG
Ai Zheng; 2006 Aug; 25(8):925-32. PubMed ID: 16965670
[TBL] [Abstract][Full Text] [Related]
31. p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage.
Yuan ZM; Shioya H; Ishiko T; Sun X; Gu J; Huang YY; Lu H; Kharbanda S; Weichselbaum R; Kufe D
Nature; 1999 Jun; 399(6738):814-7. PubMed ID: 10391251
[TBL] [Abstract][Full Text] [Related]
32. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.
Uramoto H; Izumi H; Nagatani G; Ohmori H; Nagasue N; Ise T; Yoshida T; Yasumoto K; Kohno K
Biochem J; 2003 Apr; 371(Pt 2):301-10. PubMed ID: 12534345
[TBL] [Abstract][Full Text] [Related]
33. Differential effect of ik3-1/cables on p53- and p73-induced cell death.
Tsuji K; Mizumoto K; Yamochi T; Nishimoto I; Matsuoka M
J Biol Chem; 2002 Jan; 277(4):2951-7. PubMed ID: 11706030
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cells.
Million K; Horvilleur E; Goldschneider D; Agina M; Raguénez G; Tournier F; Bénard J; Douc-Rasy S
Int J Oncol; 2006 Jul; 29(1):147-54. PubMed ID: 16773194
[TBL] [Abstract][Full Text] [Related]
35. Cooperation between p53 and p73 in cisplatin-induced apoptosis in ovarian carcinoma cells.
Righetti SC; Perego P; Carenini N; Zunino F
Cancer Lett; 2008 May; 263(1):140-4. PubMed ID: 18261847
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer.
Truninger K; Menigatti M; Luz J; Russell A; Haider R; Gebbers JO; Bannwart F; Yurtsever H; Neuweiler J; Riehle HM; Cattaruzza MS; Heinimann K; Schär P; Jiricny J; Marra G
Gastroenterology; 2005 May; 128(5):1160-71. PubMed ID: 15887099
[TBL] [Abstract][Full Text] [Related]
37. Regulation of p73 by Hck through kinase-dependent and independent mechanisms.
Paliwal P; Radha V; Swarup G
BMC Mol Biol; 2007 May; 8():45. PubMed ID: 17535448
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemistry of proteins for DNA mismatch repair in correlation to prognostic factors of mammarian cancer.
Köster F; Schröer A; Fischer D; Horn AK; Diedrich K; Friedrich M
Oncol Rep; 2007 May; 17(5):1223-7. PubMed ID: 17390069
[TBL] [Abstract][Full Text] [Related]
39. Involvement of p53 mutation and mismatch repair proteins dysregulation in NNK-induced malignant transformation of human bronchial epithelial cells.
Shen Y; Zhang S; Huang X; Chen K; Shen J; Wang Z
Biomed Res Int; 2014; 2014():920275. PubMed ID: 25215298
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents.
Francia G; Green SK; Bocci G; Man S; Emmenegger U; Ebos JM; Weinerman A; Shaked Y; Kerbel RS
Mol Cancer Ther; 2005 Oct; 4(10):1484-94. PubMed ID: 16227397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
